Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/2445/148047
| dc.contributor.author | Giménez Carabaza, Neus |
|---|---|
| dc.contributor.author | Martínez Trillos, Alejandra |
| dc.contributor.author | Montraveta, Arnau |
| dc.contributor.author | López-Guerra, Mónica |
| dc.contributor.author | Rosich, Laia |
| dc.contributor.author | Nadeu, Ferran |
| dc.contributor.author | Valero, Juan G. |
| dc.contributor.author | Aymerich Gregorio, Marta |
| dc.contributor.author | Magnano, Laura |
| dc.contributor.author | Rozman, María |
| dc.contributor.author | Matutes, Estella |
| dc.contributor.author | Delgado, Julio (Delgado González) |
| dc.contributor.author | Baumann, Tycho |
| dc.contributor.author | Gine, Eva |
| dc.contributor.author | González, Marcos |
| dc.contributor.author | Alcoceba, Miguel |
| dc.contributor.author | Terol, Maria José |
| dc.contributor.author | Navarro, Blanca |
| dc.contributor.author | Colado, Enrique |
| dc.contributor.author | Payer, Ángel R. |
| dc.contributor.author | Puente, Xose S. |
| dc.contributor.author | López-Otin, Carlos |
| dc.contributor.author | López Guillermo, Armando |
| dc.contributor.author | Campo Güerri, Elias |
| dc.contributor.author | Colomer Pujol, Dolors |
| dc.contributor.author | Villamor i Casas, Neus |
| dc.date | 2020-01-16T15:18:40Z |
| dc.date | 2020-01-16T15:18:40Z |
| dc.date | 2019-03 |
| dc.date | 2020-01-16T15:18:40Z |
| dc.identifier | 0390-6078 |
| dc.identifier | 682538 |
| dc.identifier | 3998691 |
| dc.identifier.uri | http://hdl.handle.net/2445/148047 |
| dc.description | Mutations in genes of the RAS-BRAF-MAPK-ERK pathwayhave not been fully explored in patients with chronic lym-phocytic leukemia. We, therefore, analyzed the clinical andbiological characteristics of chronic lymphocytic leukemia patientswith mutations in this pathway and investigated thein vitroresponseof primary cells to BRAF and ERK inhibitors. Putative damaging muta-tions were found in 25 of 452 patients (5.5%). Among these, BRAFwas mutated in nine patients (2.0%), genes upstream of BRAF(KITLG,KIT, PTPN11, GNB1, KRASand NRAS) were mutated in 12 patients(2.6%), and genes downstream of BRAF(MAPK2K1, MAPK2K2, andMAPK1) were mutated in five patients (1.1%). The most frequentmutations were missense, subclonal and mutually exclusive. Patientswith these mutations more frequently had increased lactate dehydro-genase levels, high expression of ZAP-70, CD49d, CD38, trisomy 12and unmutated immunoglobulin heavy-chain variable region genesand had a worse 5-year time to first treatment (hazard ratio 1.8,P=0.025). Gene expression analysis showed upregulation of genes ofthe MAPK pathway in the group carrying RAS-BRAF-MAPK-ERKpathway mutations. The BRAF inhibitors vemurafenib and dabrafenibwere not able to inhibit phosphorylation of ERK, the downstreameffector of the pathway, in primary cells. In contrast, ulixertinib, apan-ERK inhibitor, decreased phospho-ERK levels. In conclusion,although larger series of patients are needed to corroborate these find-ings, our results suggest that the RAS-BRAF-MAPK-ERK pathway isone of the core cellular processes affected by novel mutations inchronic lymphocytic leukemia, is associated with adverse clinical fea-tures and could be pharmacologically inhibited. |
| dc.format | 11 p. |
| dc.format | application/pdf |
| dc.language | eng |
| dc.publisher | Ferrata Storti Foundation |
| dc.relation | Reproducció del document publicat a: https://doi.org/10.3324/haematol.2018.196931 |
| dc.relation | Haematologica, 2019, vol. 104, num. 3, p. 576-586 |
| dc.relation | https://doi.org/10.3324/haematol.2018.196931 |
| dc.relation | info:eu-repo/grantAgreement/EC/FP7/306240/EU//SYSTEMAGE |
| dc.rights | (c) Ferrata Storti Foundation, 2018 |
| dc.rights | info:eu-repo/semantics/openAccess |
| dc.subject | Leucèmia limfocítica crònica |
| dc.subject | Mutació (Biologia) |
| dc.subject | Chronic lymphocytic leukemia |
| dc.subject | Mutation (Biology) |
| dc.title | Mutations in RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemia |
| dc.type | info:eu-repo/semantics/article |
| dc.type | info:eu-repo/semantics/publishedVersion |
Documentos relacionados
Otros documentos del mismo autor/a
Giménez, Neus; Martínez-Trillos, Alejandra; Montraveta, Arnau; Lopez Guerra, Mónica; Rosich, Laia; Nadeu, Ferran; Valero, Juan G.; Aymerich Gregorio, Marta; Magnano, Laura; Rozman, María; Matutes, Estella; Delgado, Julio; Baumann, Tycho; Gine, Eva; González, Marcos; Alcoceba, Miguel; Terol, M.José; Navarro, Blanca; Colado, Enrique; Payer, Angel R.; Puente, Xose S.; López Otín, Carlos; López-Guillermo, Armando; Campo Güerri, Elias; Colomer Pujol, Dolors; Villamor i Casas, Neus
Delgado, Julio (Delgado González); Salaverria Frigola, Itziar; Baumann, Tycho; Martínez Trillos, Alejandra; Lee, Eriong; Jiménez, Laura; Navarro López, Alba; Royo Moreno, Cristina; Santacruz, Rodrigo; López, Cristina; Payer, Ángel R.; Colado, Enrique; González, Marcos; Armengol, Lluís; Colomer Pujol, Dolors; Pinyol, Magda; Villamor i Casas, Neus; Aymerich Gregorio, Marta; Carrió, Ana; Costa, Dolors; Clot, Guillem; Giné Soca, Eva; López Guillermo, Armando; Campo Güerri, Elias; Beà Bobet, Sílvia M.
Delgado, Julio (Delgado González); Salaverria Frigola, Itziar; Baumann, Tycho; Martínez Trillos, Alejandra; Lee, Eriong; Jiménez, Laura; Navarro López, Alba; Royo Moreno, Cristina; Santacruz, Rodrigo; López, Cristina; Payer, Ángel R.; Colado, Enrique; González, Marcos; Armengol, Lluís; Colomer Pujol, Dolors; Pinyol, Magda; Villamor i Casas, Neus; Aymerich Gregorio, Marta; Carrió, Ana; Costa, Dolors; Clot, Guillem; Giné Soca, Eva; López Guillermo, Armando; Campo Güerri, Elias; Beà Bobet, Sílvia M.
Ferreira, Pedro G.; Jares Gerboles, Pedro; Rico, Daniel; Gómez López, Gonzalo; Martínez Trillos, Alejandra; Villamor i Casas, Neus; Ecker, Simone; González-Pérez, Abel; Knowles, David G.; Monlong, Jean; Johnson, Rory; Quesada, Victor; Djebali, Sarah; Papasaikas, Panagiotis; López-Guerra, Mónica; Colomer Pujol, Dolors; Royo Moreno, Cristina; Cazorla, Maite; Pinyol, Magda; Clot, Guillem; Aymerich Gregorio, Marta; Rozman, María; Kulis, Marta; Tamborero Noguera, David; Gouin, Anaïs; Blanc, Julie; Gut, Marta; Gut, Ivo G.; Puente, Xose S.; Pisano, David G.; Martín-Subero, José Ignacio; López Bigas, Núria; López Guillermo, Armando; Valencia, Alfonso; López-Otin, Carlos; Campo Güerri, Elias; Guigó Serra, Roderic
Santacruz, Rodrigo; Villamor i Casas, Neus; Aymerich Gregorio, Marta; Martínez Trillos, Alejandra; López, Cristina; Navarro López, Alba; Rozman, María; Beà Bobet, Sílvia M.; Royo Moreno, Cristina; Cazorla, Maite; Colomer Pujol, Dolors; Giné Soca, Eva; Pinyol, Magda; Puente, Xose S.; López-Otin, Carlos; Campo Güerri, Elias; López Guillermo, Armando; Delgado, Julio (Delgado González)